Tuvusertib in Astrocytoma With ATRX Mutation

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Astrocytoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Hospital Universitario Son Espases, Palma de Mallorca, Balearic Islands, Spain

    Contact: Study coordinator (Responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412
    Contact: Principal Investigator (Principal investigator Designated by the Sponsor, MD)
  • Hospital Universitario Vall d'Hebron, Barcelona, Barcelona, Spain

    Contact: Study coordinator (Responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412
    Contact: Principal Investigator (Principal investigator Designated by the Sponsor, MD)
  • Hospital Clinic de Barcelona, Barcelona, Barcelona, Spain

    Contact: Study coordinator (Responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412
    Contact: Principal Investigator (Principal investigator Designated by the Sponsor, MD)
  • Hospital Universitario de Cruces, Barakaldo, Bizkaia, Spain

    Contact: Study coordinator (Responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412
    Contact: Principal Investigator (Principal investigator Designated by the Sponsor, MD)
  • Hospital Universitario Virgen de las Nieves, Granada, Granada, Spain

    Contact: Study coordinator (Responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412
    Contact: Principal Investigator (Principal investigator Designated by the Sponsor, MD)
  • Hospital Universitario Ramón y Cajal, Madrid, Madrid, Spain

    Contact: Study coordinator (Responsible person Designated by the Sponsor) · Investigacion@mfar.net · 0034934344412
    Contact: Principal Investigator (Principal investigator Designated by the Sponsor, MD)
  • Hospital Álvaro Cunqueiro, Vigo, Pontevedra, Spain

    Contact: Study coordinator (Responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412
    Contact: Principal Investigator (Principal investigator Designated by the Sponsor, MD)
  • Hospital Clínico Universitario de Salamanca, Salamanca, Salamanca, Spain

    Contact: Study coordinator (Resposible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412
    Contact: Principal Investigator (Principal investigator Designated by the Sponsor, MD)
  • Hospital Universitario Virgen del Rocío, Seville, Sevilla, Spain

    Contact: Study coordinator (Responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412
    Contact: Principal Investigator (Principal investigator Designated by the Sponsor, MD)
  • Hospital Clínico Universitario de Valencia - INCLIVA, Valencia, Valencia, Spain

    Contact: Study coordinator (Responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412
    Contact: Principal Investigator (Principal investigator Designated by the Sponsor, MD)
מובילי המחקר
  • Estela Pineda, M.D.; Ph.D.

    Study Chair

    Medical Oncology, Hospital Clínic de Barcelona

  • Maria Vieito, M.D.; Ph.D.

    Study Chair

    Medical Oncology, Hospital Universitari Vall d'Hebrón